![AbbVie : FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with Spasticity | World Pharma Today AbbVie : FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with Spasticity | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/2020/07/botox.jpg)
AbbVie : FDA Approves Expanded BOTOX Label for the Treatment of Pediatric Patients with Spasticity | World Pharma Today
![ABBVIE: FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity | FDA Health News ABBVIE: FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity | FDA Health News](https://s3.amazonaws.com/jnswire/jns-media/db/80/1364476/fdaapproval.jpg)
ABBVIE: FDA Approves Expanded BOTOX® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity | FDA Health News
![FDA Approves Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity | News | Spinal Cord Injury Zone! FDA Approves Expanded BOTOX® Label to Include Eight New Muscles to Treat Adults with Upper Limb Spasticity | News | Spinal Cord Injury Zone!](https://spinalcordinjuryzone.com/wp-content/media/botox-injection.png)